Tempol Recruiting Phase 2 Trials for Ototoxicity / Mucositis / Nephrotoxicity Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03480971Treatment of Radiation and Cisplatin Induced Toxicities With Tempol